Label Image (Lbl500906218)
Segluromet
Product Images NDC 50090-6218
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Segluromet (NDC 50090-6218). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Segluromet 01)
Chemical Structure (Segluromet 02)
Figure 1 (Segluromet 03)
This is a list of medications with their corresponding doses. The medications include Sitagliptin, Metiormin, Glimepiride, Simvastatin, and Ritampin. The doses are given in milligrams and are taken once daily, with the exception of Ritampin which is taken once daily. There is also a table with values for Auc, cmax, and geometric mean ratio. The last part of the text is information about the relative effect of a medication called ertugiflozin at different doses.*
Figure 2 (Segluromet 04)
This is a prescription record for a patient with four medications: Sitagliptin, Metiormin, Glimepiride, and Simvastatin. The dosage for each medication is also noted as a single dose. The rest of the text seems to be statistical data regarding the effectiveness of these medications when administered alone and with other medications, mentioning ratios and percentages. The medication Al ertugifiozin is also mentioned but only notes that it was given as a 15mg single dose.*
Figure 3 (Segluromet 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
